Total Payments
$7,614
2024 Payments
$80.44
Companies
21
Transactions
46
Medicare Patients
4,553
Medicare Billing
$488,094
Payment Breakdown by Category
Research$4,540 (59.6%)
Consulting$2,295 (30.1%)
Food & Beverage$731.74 (9.6%)
Education$47.47 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4,540 | 1 | 59.6% |
| Consulting Fee | $2,295 | 1 | 30.1% |
| Food and Beverage | $731.74 | 41 | 9.6% |
| Education | $47.47 | 3 | 0.6% |
Payments by Type
Research
$4,540
1 transactions
General
$3,074
45 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $4,540 | 1 | $0 (2022) |
| Novo Nordisk Inc | $2,414 | 8 | $0 (2023) |
| ABBVIE INC. | $106.00 | 6 | $0 (2022) |
| Medtronic, Inc. | $97.65 | 5 | $0 (2024) |
| Amgen Inc. | $68.12 | 4 | $0 (2024) |
| Senseonics, Incorporated | $43.00 | 2 | $0 (2018) |
| Tandem Diabetes Care, Inc. | $40.29 | 3 | $0 (2022) |
| Abbott Laboratories | $37.28 | 2 | $0 (2024) |
| Lilly USA, LLC | $34.56 | 2 | $0 (2022) |
| Nevro Corp. | $33.71 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.44 | 4 | Amgen Inc. ($34.00) |
| 2023 | $158.18 | 9 | Medtronic, Inc. ($38.70) |
| 2022 | $4,642 | 7 | Eli Lilly and Company ($4,540) |
| 2021 | $180.01 | 9 | Novo Nordisk Inc ($35.78) |
| 2020 | $2,295 | 1 | Novo Nordisk Inc ($2,295) |
| 2019 | $16.77 | 1 | Shire North American Group Inc ($16.77) |
| 2018 | $130.34 | 7 | Senseonics, Incorporated ($43.00) |
| 2017 | $111.15 | 8 | AbbVie, Inc. ($40.41) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes Care | ||||||
| 05/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Durable Pump | ||||||
| 03/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Bone Health | ||||||
| 10/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Neuromodulation | ||||||
| 09/22/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Durable Pump | ||||||
| 08/25/2023 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: OSTEOPOROSIS | ||||||
| 07/04/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Durable Pump | ||||||
| 06/02/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Diabetes | ||||||
| 05/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Obesity | ||||||
| 05/05/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/17/2023 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/21/2022 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Diabetes | ||||||
| 09/16/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Endocrinology | ||||||
| 07/15/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 04/08/2022 | Eli Lilly and Company | — | — | In-kind items and services | $4,540.00 | Research |
| Study: A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES | ||||||
| 02/21/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/19/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 12/10/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2021 | Medtronic, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/12/2021 | RECORDATI_RARE_DISEASES_INC. | — | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| 11/06/2021 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES | Eli Lilly and Company | $4,540 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,073 | 1,414 | $339,857 | $117,029 |
| 2022 | 7 | 1,143 | 1,528 | $363,952 | $125,657 |
| 2021 | 9 | 1,221 | 1,656 | $393,881 | $142,446 |
| 2020 | 7 | 1,116 | 1,440 | $333,966 | $102,962 |
Total Patients
4,553
Total Services
6,038
Medicare Billing
$488,094
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 707 | 970 | $232,800 | $86,236 | 37.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 196 | 209 | $61,237 | $16,456 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $22,200 | $6,961 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $7,871 | $2,821 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 38 | $6,004 | $2,345 | 39.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 42 | 65 | $6,500 | $1,625 | 25.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 55 | $3,245 | $585.29 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 789 | 1,078 | $258,720 | $95,903 | 37.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 189 | 207 | $60,651 | $16,435 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $19,610 | $5,879 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 45 | $7,110 | $2,791 | 39.3% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 20 | 20 | $7,780 | $2,201 | 28.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 35 | 66 | $6,600 | $1,768 | 26.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 59 | $3,481 | $680.19 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 761 | 1,110 | $266,400 | $102,400 | 38.4% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 202 | 219 | $64,167 | $19,171 | 29.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $21,830 | $6,973 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 100 | $15,800 | $6,260 | 39.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $6,945 | $2,719 | 39.2% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 20 | 20 | $7,780 | $2,050 | 26.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 38 | 74 | $7,400 | $2,028 | 27.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 16 | 46 | $2,714 | $488.15 | 18.0% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 13 | 13 | $845.00 | $355.81 | 42.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 697 | 946 | $227,040 | $71,077 | 31.3% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 163 | 175 | $51,275 | $15,020 | 29.3% |
About Dr. Valerie Espinosa, M.D
Dr. Valerie Espinosa, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649245697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Valerie Espinosa, M.D has received a total of $7,614 in payments from pharmaceutical and medical device companies, with $80.44 received in 2024. These payments were reported across 46 transactions from 21 companies. The most common payment nature is "" ($4,540).
As a Medicare-enrolled provider, Espinosa has provided services to 4,553 Medicare beneficiaries, totaling 6,038 services with total Medicare billing of $488,094. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 02/22/2006
- Last Updated 01/06/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1649245697
Products in Payments
- MINIMED 780G (Device) $63.01
- Eversense (Device) $43.00
- SYNTHROID (Drug) $40.89
- Androgel (Drug) $40.41
- Wegovy (Drug) $36.86
- Omnia (Device) $33.71
- Pogo Automatic Blood Glucose Monitoring System (Device) $30.63
- Synthroid (Drug) $24.70
- t-slim insulin pump (Device) $23.70
- InPen (Device) $23.15
- BAQSIMI (Drug) $22.85
- FREESTYLE LIBRE 3 (Device) $22.13
- LEQVIO (Drug) $20.93
- TERIPARATIDE (Drug) $20.14
- Victoza (Drug) $19.36
- EVKEEZA (Biological) $18.99
- Ozempic (Drug) $18.70
- TEPEZZA (Biological) $18.47
- Prolia (Biological) $18.27
- Rybelsus (Drug) $17.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Endocrinology, Diabetes & Metabolism $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Endocrinology, Diabetes & Metabolism $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Endocrinology, Diabetes & Metabolism $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Endocrinology, Diabetes & Metabolism $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161
Endocrinology, Diabetes & Metabolism $9,161